Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ADS DiagnosticsBOM:523031 PEG Ratio is 0.17 as of Aug. 04, 2026, which is 21% above its 10-year median of 0.14. The stock has 3 warning signs investors should review.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for ADS Diagnostics's PEG Ratio or its related term are showing as below:
BOM:523031'
s PEG Ratio Range Over the Past 10 Years
Min: 0.12 Med: 0.14 Max: 0.93
Current: 0.17
During the past 13 years, ADS Diagnostics's highest PEG Ratio was 0.93. The lowest was 0.12. And the median was 0.14.
BOM:523031's PEG Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 1.955
vs BOM:523031: 0.17
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
ADS Diagnostics (BOM:523031) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
ADS Diagnostics PEG Ratio Related Terms
ADS Diagnostics PEG Ratio Historical Data
* Premium members only.
The historical data trend for ADS Diagnostics's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:523031 vs OZSC, WHSI, LENSF: PEG Ratio Comparison
For the Medical Devices subindustry, ADS Diagnostics's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ADS Diagnostics PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ADS Diagnostics's PEG Ratio distribution charts can be found below:
* The bar in red indicates where ADS Diagnostics's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
ADS Diagnostics (BOM:523031) has a PEG Ratio of 0.17 as of Aug. 04, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on ADS Diagnostics and its competitors. This is 21% above median its historical median of 0.14. Over the past decade, ADS Diagnostics' PEG Ratio has ranged from 0.12 to 0.93.
Is ADS Diagnostics' PEG Ratio too high?
ADS Diagnostics' current PEG Ratio of 0.17 is 21% above median its 10-year median of 0.14. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 0.93. The Medical Devices & Instruments industry median PEG Ratio is 1.96. ADS Diagnostics' value of 0.17 is 91.3% below this industry median.
How does ADS Diagnostics' PEG Ratio compare to OZSC and WHSI?
ADS Diagnostics' PEG Ratio of 0.17 can be compared against companies in the Medical Devices & Instruments industry. The industry median PEG Ratio is 1.96. ADS Diagnostics' value of 0.17 is 91.3% below this benchmark. Historically, ADS Diagnostics' own PEG Ratio has ranged from 0.12 to 0.93 over the past decade. While the company's 10-year median is 0.14 vs. the industry median of 1.96, ADS Diagnostics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 1.96, based on 206 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ADS Diagnostics's current PEG Ratio of 0.17 is 91.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on ADS Diagnostics and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ADS Diagnostics's current PEG Ratio is 0.17, which is 21% above median its own 10-year median of 0.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ADS Diagnostics stock overvalued right now?
ADS Diagnostics (BOM:523031) has a current PEG Ratio of 0.17. The stock's GF Value™ is ₹11.48, compared to a current price of ₹11.34 — trading 1.2% below its estimated fair value. The current PEG Ratio is 0.17, which is 21% above median its 10-year median of 0.14 and 91.3% below the Medical Devices & Instruments industry median of 1.96. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For ADS Diagnostics (BOM:523031), the current PEG Ratio is 0.17 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ADS Diagnostics Ltd is an India-based company engaged in the sale of medical equipment. It is focused on the business activity of the sale of trading goods, servicing and installation of medical equipment, lease rental, and distribution. The company generates key revenue from the sale of trading goods. It sells its products and services in India and internationally.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:523031 has been successfully added to your 
